The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Incyte Corporation(NASDAQ:INCY) 
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; PEMAZYRE, a fibrobla...
Website: http://www.incyte.com
Founded: 2002
Full Time Employees: 1,456
Sector: Healthcare
Industry: Biotechnology
Incyte Days Payable Outstanding ttm (DPO)
Incyte Days Receivable Outstanding ttm (DSO)
Incyte Days Inventory Outstanding ttm (DIO)
Incyte Op Cashflow Per Share ttm
Incyte Free Cashflow Per Share ttm
Incyte Cash Per Share ttm
Incyte P/S ratio ttm
Incyte (GAAP) P/E ratio ttm
Incyte P/B ratio ttm
No extra charts and metrics for this ticker.